What is Corvel's granted (in shares)?

Corvel (CRVL) reported granted (in shares) of $75.32 in Q4 2025.

What does granted (in shares) mean?

The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.

Corvel CRVL Granted (in shares)

Granted (in shares) at other companies

Medline, Inc. MDLN

$0.00—

Other financials

Income statement

See full

Revenue$248.5M+7.4%

Gross profit$63.0M+8.3%

Net income$31.0M+17.4%

EPS (diluted)$0.61+19.6%

Balance sheet

See full

Cash & equivalents$233.1M+36.6%

Total debt$28.1M+0.1%

Total equity$394.2M+22.4%

Total assets$643.0M+17.8%

Cash flow

See full

Operating cash flow$29.5M+28.6%

CapEx$9.2M+5.9%

Free cash flow$20.3M+42.3%

Valuation

See full

Market cap$3.03B-51.4%

Enterprise value$2.82B-53.8%

P/E27.4×-38.0×

P/S3.2×-3.8×

Profitability

See full

Gross margin24.3%+0.9pp

Net margin11.5%+0.9pp

FCF margin11.5%+1.3pp

Returns & leverage

See full

Return on equity30.8%-2.6pp

Debt / equity0.1×0.0×

Current ratio2×+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice.

The official record: Corvel’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's granted (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvel's granted (in shares)?: Corvel (CRVL) reported granted (in shares) of $75.32 in Q4 2025.
What does granted (in shares) mean?: The weighted average exercise price of stock options granted to employees and directors during the reporting period. This metric reflects the company's cost of equity-based incentives and the strike price set for new option awards.